Finland

Committee of the Whole L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs

Secretariat: There will be an informal on L5 in a hybrid format on BR-A. L7 – Technical amendment. On OP12 & 13 – There is in square brackets ‘or trafficking’. There was an omission to delete this part. Just checking with the CoW. Ok, we can continue. United States: We engaged in consultations, not in …

Read more

Resolution L3 – Ensuring access to drug treatment, education, after-care, rehabilitation, and social reintegration services, for people within marginalized populations (cont.)

Chair: Welcome back to the Committee of the Whole. I hope you all had a good night and everybody is ready, in good spirits, and in constructive spirits. Last night, resolution six by Nigeria was agreed in the committee and submitted to the Plenary. As soon as the English version is available, it will be posted on …

Read more

Plenary – Agenda item 3: General Debate (continued)

Chair: Because of technical difficulties, we will not start with the Global Fund, so we will start with speakers left from yesterday. Please, limit your statements to 3 minutes. Kazakhstan: CND offers a unique platform to share information and strengthen cooperation. Weve all seen negative trends. This requires continued improvement and focused efforts. Important to …

Read more

Side Event: Good Practices in Cross-Sectoral Cooperation: Civil Society Involvement in Policymaking in Europe

Organized by Finland and Spain, and Civil Society Forum on Drugs in Europe, Correlation – European Harm Reduction Network, European Union, Foreningen for Human Narkotikapolitikk, International Drug Policy Consortium, Rights Reporter Foundation and Youth Organisations for Drug Action. Moderator – Marie Nougier, International Drug Policy Consortium: Talking about good practice examples of how civil society and …

Read more

Committee of the Whole (Thursday morning) L4. Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use

EC77/2020/L4   Belgium:There are some paras where the wording is ‘non-stigma’. A couple of paras have been agreed in informals pending on the solution of non-stigmatisation. Chair: Canada was the state proposing language on stigma Canada: If we are going to focus on PPs first we did have discussions during informals. Linking PP that references stigma …

Read more